バイオサージェリーの世界市場レポート 2024年

バイオサージェリー市場規模は近年力強く成長しています。2023年の140億1,000万米ドルから2024年には151億8,000万米ドルへとCAGR8.4％で拡大します。この動向は、外科手術の急増、慢性疾患の増加、高齢者層の拡大、生分解性製品を好む傾向、規制の変更、承認取得などに関連しています。

2023年のバイオサージェリー市場で最大の地域は北米でした。アジア太平洋は、バイオサージェリー市場レポートにおいて予測期間中に最も急成長する地域となる見込みです。バイオサージェリー市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 バイオサージェリー市場の特徴

第3章 バイオサージェリー市場の動向と戦略

第4章 バイオサージェリー市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界のバイオサージェリー市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 バイオサージェリー市場セグメンテーション

• 世界のバイオサージェリー市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 骨移植片代替品
• 軟組織アタッチメント
• 止血剤
• 外科手術用シーラントおよび接着剤
• 癒着バリア
• ステープルラインの補強
• 世界のバイオサージェリー市場、由来別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 天然または生物製剤
• 合成製品
• 世界のバイオサージェリー市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 整形外科
• 一般外科
• 神経外科
• 心臓血管外科
• 婦人科外科
• その他の用途
• 世界のバイオサージェリー市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• クリニック
• その他のエンドユーザー

第7章 バイオサージェリー市場の地域および国分析

• 世界のバイオサージェリー市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のバイオサージェリー市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋のバイオサージェリー市場

第9章 中国のバイオサージェリー市場

第10章 インドのバイオサージェリー市場

第11章 日本のバイオサージェリー市場

第12章 オーストラリアのバイオサージェリー市場

第13章 インドネシアのバイオサージェリー市場

第14章 韓国のバイオサージェリー市場

第15章 西欧のバイオサージェリー市場

第16章 英国のバイオサージェリー市場

第17章 ドイツのバイオサージェリー市場

第18章 フランスのバイオサージェリー市場

第19章 イタリアのバイオサージェリー市場

第20章 スペインのバイオサージェリー市場

第21章 東欧のバイオサージェリー市場

第22章 ロシアのバイオサージェリー市場

第23章 北米バイオサージェリー市場

第24章 米国のバイオサージェリー市場

第25章 カナダのバイオサージェリー市場

第26章 南米バイオサージェリー市場

第27章 ブラジルのバイオサージェリー市場

第28章 中東のバイオサージェリー市場

第29章 アフリカのバイオサージェリー市場

第30章 バイオサージェリー市場の競合情勢と企業プロファイル

• バイオサージェリー市場の競合情勢
• バイオサージェリー市場の企業プロファイル
  • Baxter International Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Hemostasis LLC
  • Integra LifeSciences Corporation

第31章 世界のバイオサージェリー市場の競合ベンチマーキング

第32章 世界のバイオサージェリー市場の競争ダッシュボード

第33章 バイオサージェリー市場における主要な合併と買収

第34章 バイオサージェリー市場の将来展望と可能性分析

第35章 付録

“Biosurgery Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosurgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosurgery? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The biosurgery market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Bone-Graft Substitutes; Soft-Tissue Attachments; Hemostatic Agents; Surgical Sealants and Adhesives; Adhesion Barriers; Staple Line Reinforcement
• 2) By Source: Natural or Biologics Products; Synthetic Products
• 3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Gynecological Surgery; Other Applications
• 4) By End-User: Hospitals; Clinics; Other End-Users
• Companies Mentioned: Baxter International Inc.; B. Braun SE; Becton, Dickinson and Company; Hemostasis LLC; Integra LifeSciences Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Biosurgery involves utilizing live maggots to remove dead tissue, minimize infection risks, and accelerate wound healing. This field encompasses semi-synthetic, synthetic, or natural materials that aid in the recuperation of surgical incisions and tissue regeneration.

Primary biosurgery products include bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcement. Bone graft substitutes are materials, natural or synthetic, used to fill bone voids and facilitate bone mending. These products stem from natural or biological sources as well as synthetic origins. They find application in orthopedic, general, neurological, cardiovascular, gynecological surgeries, and others, catering to end-users such as hospitals, clinics, and similar facilities.

The biosurgery market research report is one of a series of new reports from The Business Research Company that provides biosurgery market statistics, including biosurgery industry global market size, regional shares, competitors with a biosurgery market share, detailed biosurgery market segments, market trends and opportunities, and any further data you may need to thrive in the biosurgery industry. This biosurgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biosurgery market size has grown strongly in recent years. It will grow from $14.01 billion in 2023 to $15.18 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The expansion witnessed during the historical period can be linked to the upsurge in surgical interventions, escalation of chronic ailments, the expanding demographic of elderly individuals, a trend favoring biodegradable products, alterations in regulations, and the reception of approvals.

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $20.87 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The projected expansion in the upcoming period can be credited to progress in tissue engineering, an increase in minimally invasive techniques, a concentrated effort on regenerative medicine, a transition towards biologics, and the evolving needs of an aging population. Key trends anticipated in the forecast period encompass the surge in minimally invasive procedures, an uptick in cosmetic and plastic surgeries, a heightened focus on stem cell therapies, advancements in wound care, and the evolution of biodegradable products.

The biosurgery market is poised for growth, primarily driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for a year or longer and requiring ongoing medical care, significantly impact individuals' health, restricting daily activities. In the U.S., chronic diseases such as diabetes, cancer, and heart disease are leading causes of death and disability. Biosurgery plays a crucial role in managing chronic wounds by eliminating dead tissue, reducing infection risk, and expediting the healing process. For example, in March 2022, the Australian Bureau of Statistics reported that 78.6% of Australians suffered from at least one chronic illness, affecting over half of the population. The rise in chronic diseases is a key factor propelling the growth of the biosurgery market.

A significant factor contributing to the growth of the biosurgery market is the increase in the number of accidents. Accidents, unforeseen events causing harm or injury, occur in various settings such as daily life, workplaces, transportation, and sports. Biosurgery is utilized in accident scenarios to mitigate blood loss, facilitate effective coagulation, and promote wound healing in traumatic situations, injuries, or surgical operations. In 2022, the Department of Infrastructure, Transport, Regional Development, and Communications in Australia reported 1,194 fatal traffic accidents, indicating a 5.8% increase over the previous year. The growth in accident numbers is driving the adoption of biosurgery for effective wound management.

A notable trend in the biosurgery market is the emphasis on product innovations by major companies to strengthen their market position. For instance, Aroa Biosurgery, a New Zealand-based manufacturer of medical and surgical products, introduced Myriad Morcells in April 2021. Myriad Morcells, a Myriad Matrix morcellized (powder) configuration, enhances interaction with uneven wound beds. It delivers biologically significant extracellular matrix (ECM) proteins to kick-start the healing process. Myriad Matrix, a multi-layered ECM graft with high volume and surface area, leverages Aroa's ECM bioscaffold technology, incorporating essential secondary chemicals and persistent vascular channels to support the formation of new tissue. Product innovations such as these contribute to the competitiveness and growth of companies in the biosurgery market.

Prominent companies in the biosurgery market are increasingly adopting a strategic partnership approach to enhance their capabilities and expand their market presence. Strategic partnerships involve leveraging the strengths and resources of collaborating companies for mutual benefits and success. In a notable example, Biocomposites Ltd., a UK-based manufacturing company specializing in calcium compound solutions for bone and soft tissue regeneration and repair, entered into an agreement with Zimmer Biomet Holdings Inc. in March 2022. Under this agreement, Biocomposites exclusively sells genex Bone Graft Substitute in the US orthopedic market. Genex Bone Graft Substitute is a biphasic composite with excellent purity, precisely developed to balance osteoconductive scaffold toughness and persistence in the body, facilitating optimal bone architecture rebuilding. The partnership includes enhancements for the US market, incorporating a new closed-mixing method to save preparation time and extend working time. It also offers a broader range of delivery options, enabling surgeons to inject, shape, or prepare beads according to their preferred approach.

In December 2021, Becton, Dickinson (BD) and Company, a US-based medical technology company, acquired Tissuemed Ltd., for an undisclosed amount. This acquisition enables BD to strengthen Tissuemed's position as a leader in the rapidly expanding global market for sealant technology. Tissuemed, based in the UK, is a medical technology company specializing in the development of tissue-based therapeutic devices and bioadhesive films used in biosurgery. Through strategic partnerships and acquisitions, major companies are actively shaping the landscape of the biosurgery market, ensuring competitiveness and a broader reach in the evolving healthcare landscape.

Major companies operating in the biosurgery market report are Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., CSL Limited, Pfizer Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smiths & Nephew plc, Medtronic plc, Stryker Corp., Cyrolife Inc., Betatech Medical, Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom'Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Endo International plc, Genzyme Corporation, Takeda Pharmaceutical Company Limited, Cerus Corporation .

North America was the largest region in the biosurgery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biosurgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biosurgery market consists of revenues earned by entities by providing biosurgery services such as maggot therapy, transplantation, and autologous chondrocyte implantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The biosurgery market also includes sales of absorbable hemostats and surgical sealants which are used in providing biosurgery services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Biosurgery Market Characteristics

3. Biosurgery Market Trends And Strategies

4. Biosurgery Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Biosurgery Market Size and Growth

• 5.1. Global Biosurgery Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Biosurgery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Biosurgery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biosurgery Market Segmentation

• 6.1. Global Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Bone-Graft Substitutes
• Soft-Tissue Attachments
• Hemostatic Agents
• Surgical Sealants and Adhesives
• Adhesion Barriers
• Staple Line Reinforcement
• 6.2. Global Biosurgery Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Natural or Biologics Products
• Synthetic Products
• 6.3. Global Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Other Applications
• 6.4. Global Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Other End-Users

7. Biosurgery Market Regional And Country Analysis

• 7.1. Global Biosurgery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Biosurgery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biosurgery Market

• 8.1. Asia-Pacific Biosurgery Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biosurgery Market

• 9.1. China Biosurgery Market Overview
• 9.2. China Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biosurgery Market

• 10.1. India Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biosurgery Market

• 11.1. Japan Biosurgery Market Overview
• 11.2. Japan Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biosurgery Market

• 12.1. Australia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biosurgery Market

• 13.1. Indonesia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biosurgery Market

• 14.1. South Korea Biosurgery Market Overview
• 14.2. South Korea Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biosurgery Market

• 15.1. Western Europe Biosurgery Market Overview
• 15.2. Western Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biosurgery Market

• 16.1. UK Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biosurgery Market

• 17.1. Germany Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biosurgery Market

• 18.1. France Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biosurgery Market

• 19.1. Italy Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biosurgery Market

• 20.1. Spain Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biosurgery Market

• 21.1. Eastern Europe Biosurgery Market Overview
• 21.2. Eastern Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biosurgery Market

• 22.1. Russia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biosurgery Market

• 23.1. North America Biosurgery Market Overview
• 23.2. North America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biosurgery Market

• 24.1. USA Biosurgery Market Overview
• 24.2. USA Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biosurgery Market

• 25.1. Canada Biosurgery Market Overview
• 25.2. Canada Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biosurgery Market

• 26.1. South America Biosurgery Market Overview
• 26.2. South America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biosurgery Market

• 27.1. Brazil Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biosurgery Market

• 28.1. Middle East Biosurgery Market Overview
• 28.2. Middle East Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biosurgery Market

• 29.1. Africa Biosurgery Market Overview
• 29.2. Africa Biosurgery Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Biosurgery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biosurgery Market Competitive Landscape And Company Profiles

• 30.1. Biosurgery Market Competitive Landscape
• 30.2. Biosurgery Market Company Profiles
  • 30.2.1. Baxter International Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. B. Braun SE
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Becton, Dickinson and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Hemostasis LLC
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Integra LifeSciences Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Biosurgery Market Competitive Benchmarking

32. Global Biosurgery Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biosurgery Market

34. Biosurgery Market Future Outlook and Potential Analysis

• 34.1 Biosurgery Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Biosurgery Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Biosurgery Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer